Plasma exosomal miRNA-205 can be used for early diagnosis and prognostic evaluation of ovarian cancer

zehua zhu,Zehua Zhu,Zhaojun Chen,Mingxin Wang,Min Zhang,Yiwen Chen,Xiao Yang,Changjun Zhou,Yuhua Liu,Liquan Hong,Lahong Zhang

DOI: https://doi.org/10.21203/rs.3.rs-885724/v1

2021-09-20

Abstract:Abstract Background Ovarian cancer (OC) is a serious threat to women's health around the world and new biomarkers are urgently needed for early detection. Our previous published research have confirmed that miR-205 can promote the invasion and metastasis of OC cells by inhibiting the expression of the tumor suppressor gene TCF21. This study is based on the previous work, using exosomal liquid biopsy technology to detect the expression levels of the four genes miR-205, CA125, HE4 and TCF21 in the plasma exosomes of OC patients; at the same time, combined with the clinicopathological parameters of OC patients data analysis aims to provide efficient and non-invasive laboratory testing basis for the early diagnosis of OC. Methods Collected 36 OC patients diagnosed in local hospitals from September 2020 to July 2021 as OC group, selected 31 cases of surgically diagnosed ovarian benign lesions for benign group and 32 healthy people who underwent physical examination during the same period as a control group, and used transmission electron microscope (TEM), western blotting (WB) and nanoparticle tracking analysis (NTA) to identify after extracting plasma exosomes from kits. The expression levels of miR-205, CA125, HE4 and TCF21 genes in plasma exosomes were detected by real-time fluorescence quantitative PCR (qRT-PCR) method. At the same time, combined with the relationship between clinical pathological parameters in OC patients, the Receiver Operating Characteristic (ROC) curves were used to evaluate the diagnostic efficacy of plasma exosomal miR-205, CA125, HE4 and TCF21 for OC. Results Plasma exosomes were successfully isolated; the expression level of plasma exosomal miR-205 in the OC group was higher than that of the benign group and the control group, and the difference was statistically significant ( P < 0.05); plasma exosomal miR-205 was elevated during the III-IV period of OC and lymph node metastasis; combined detection of plasma exosomal miR-205 can improve the diagnostic ability of OC. Conclusion The plasma exosomal miR-205 can be used as a potential tumor biomarker to improve the diagnostic effectiveness of OC.